METZGER MICHAEL A (President and COO) received a stock award from SYNDAX PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/7/2025ACC: 0000950170-25-016384
Officer· President and COO
Since Feb 2019
+513.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
513.50K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+60.50K
Price / share
—
Trade value
—
% of position
36.9%
2/5/2025
163.91K→224.41K
Common Stock
Direct
Shares
+89K
Price / share
—
Trade value
—
% of position
39.7%
2/5/2025
224.41K→313.41K
Total
Net shares
+149.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/5/2025 | A · Award | +60.50K | — | — | 36.9% | 163.91K | 224.41K |
| Common Stock Direct | 2/5/2025 | A · Award | +89K | — | — | 39.7% | 224.41K | 313.41K |
| Total | +149.50K | $0.00 | ||||||
Derivative Transactions1
Stock Options (Right to buy)
Direct
Converts to
Common Stock
364K shares
Shares
+364K
Strike price
14.65
Held after
364K
Exercisable
—
2/5/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock364K shares | 2/5/2025 | A · Award | +364K | 14.65 | — | 364K |